RITIS SHYANTI
Also known as: RITIS K SHYANTI, RITIS SHYANTI K, RITIS KUMAR SHYANTI, RITIS SHYANTI
Alabama State University, Jawaharlal Nehru University, Rashtrasant Tukadoji Maharaj Nagpur University, University of Pittsburgh Medical Center
Research areas: Medicine · Oncology · Cancer Cells and Metastasis · Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses
0000-0002-2930-6332
About
I am an Assistant Professor in the Department of Biological Sciences at Alabama State University (ASU). My research focuses on basic and translational biomedical sciences, specifically exploring tumor immunology, host-microbe interactions, and the molecular pathways regulating epithelial-mesenchymal transition (EMT) in mucosal malignancies. Previously, I served as a Research Scientist within the Cancer Biology Research and Training (CBRT) program at ASU, where my research on CD1d-mediated lipid antigen presentation and tumor migration was supported by a Clinical Scientist Development Grant from the American Cancer Society. My expertise spans molecular oncology, cellular biology, nanotechnology, and preclinical drug screening across multiple in vitro and in vivo epithelial cancer models (including head and neck, breast, and prostate). In my current faculty role, I am committed to advancing host-pathogen research, securing federal pilot funding, and mentoring undergraduate students in advanced laboratory techniques
Employment
-
Alabama State University Assistant Professor2026 - Present
-
Alabama State University Adjunct Faculty2025 - 2026
-
Alabama State University Research Scientist2023 - 2026
-
Alabama State University Postdoctoral Research Associate2022 - 2023
-
Jawaharlal Nehru University ICMR Research Scientist IV2022 - 2022
-
Jawaharlal Nehru University RESEARCH ASSOCIATE2018 - 2022
-
University of Pittsburgh Medical Center Basic Health Science Fellow2013 - 2013
Education
- 2009 - 2010
- 2006 - 2008
Projects & Funding
-
NKT (Natural Killer T) cells dependent and independent CD1d interaction and its impact on breast cancer American Cancer Society2023 - 2026
Publications (25)
- Beyond Antigen Presentation: The Intrinsic Role of Tumor-Cell CD1d Expression in Cancer Save
- Zerumbone mediated CD1d inhibition suppresses epithelial to mesenchymal transition in triple negative breast cancer. Save
- Thymoquinone Enhances Tamoxifen Efficacy Against Triple‐Negative Breast Cancer by Targeting EMT Signaling Save
- Role of histone acetylation in the regulation of CD36 and ANGPTL1 in esophageal squamous cell carcinoma Save
- Uncovering functional divergence and cellular clusters with specific gene signatures in HNSCC clonal spheroids Save
- Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents Save
- Gut dysbiosis impacts the immune system and promotes prostate cancer Save
- Thespesia lampas mediated green synthesis of silver and gold nanoparticles for enhanced biological applications Save
- Clonal spheroids capture functional and genetic heterogeneity of head and neck cancer Save
- Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells Save
- Polydatin inhibits histone deacetylase 1 and shows an anti-angiogenic action in head and neck squamous cell carcinoma Save
- Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer Save
- Abstract 3520: Single cell-derived spheroids capture functional and genetic heterogeneity of head and neck cancer Save
- Ribes nigrum Save
- Abstract 10: Development of single cell spheroid as a tool to capture functional heterogeneity in head and neck cancer Save
- Influence of anthropocene climate change on biodiversity loss in different ecosystems Save
- Influence of anthropocene climate change on biodiversity loss in different ecosystems Save
- Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells Save
- Plant-Mediated Synthesis of Silver and Gold Nanoparticles for Antibacterial and Anticancer Applications Save
- Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down-regulation of Akt Save